OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and ...

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and ...

Sandoz has appointed Armin Metzger as President, Biosimilar Development, Manufacturing & Supply. Metzger will also become a ...

The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...

BioDuro has appointed Andrew Thomas (top left) and Stevan Djuric (top right) as Scientific Advisors.

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has appointed H. Martin Seidel to its Scientific Advisory ...

Imfinzi (durvalumab), in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel), has received EU approval. The perioperative immunotherapy was ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Leqselvi (deuruxolitinib), made by Sun Pharma UK, as a treatment for severe alopecia areata in adults. Alopecia areata is a ...

L-R: Brian Morrissey, General Manager, Michael Gately, Head of Operations and Declan Hoare, Head of Quality meet with the ...

Inizio Ignite has made five appointments to its key leadership amid the unification of four teams, Research Partnership, ...

Bristol Myers Squibb’s (BMY) Sotyktu has been approved by the US FDA to treat adults with active psoriatic arthritis (PsA). The approval is based on positive results from two phase 3 trials (POETYK ...